Allergy Therapeutics plc
AGY.L · LSE
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £13 | £13 | £15 | £21 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £8 | £8 | £7 | £10 |
| Inventory | £14 | £13 | £12 | £11 |
| Other Curr. Assets | £0 | £0 | £0 | £0 |
| Total Curr. Assets | £35 | £33 | £34 | £42 |
| Property Plant & Equip (Net) | £24 | £24 | £23 | £20 |
| Goodwill | £3 | £3 | £3 | £3 |
| Intangibles | £1 | £1 | £4 | £5 |
| Long-Term Investments | £0 | £0 | £0 | £0 |
| Tax Assets | £2 | £0 | £0 | £0 |
| Other NC Assets | £3 | £3 | £2 | £2 |
| Total NC Assets | £33 | £31 | £33 | £31 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £68 | £65 | £67 | £73 |
| Liabilities | – | – | – | – |
| Payables | £4 | £4 | £4 | £4 |
| Short-Term Debt | £2 | £2 | £2 | £2 |
| Tax Payable | £1 | £5 | £4 | £4 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £19 | £10 | £8 | £7 |
| Total Curr. Liab. | £27 | £21 | £19 | £18 |
| LT Debt | £58 | £29 | £34 | £8 |
| Deferred Rev, NC | £0 | £0 | £8 | £7 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £10 | £11 | £11 | £8 |
| Total NC Liab. | £69 | £41 | £46 | £17 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £7 | £8 | £9 | £8 |
| Total Liabilities | £96 | £61 | £65 | £35 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £1 | £0 |
| Common Stock | £5 | £5 | £1 | £1 |
| Retained Earnings | -£195 | -£199 | -£122 | -£78 |
| AOCI | £8 | £1 | £3 | £3 |
| Other Equity | £155 | £197 | £119 | £113 |
| Total Equity | -£28 | £4 | £2 | £38 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £68 | £65 | £67 | £73 |
| Net Debt | £47 | £18 | £21 | -£10 |